Genentech's Pulmozyme Drug Overview & Outlook 2016-2025: A Recombinant Form of Human Deoxyribonuclease I Produced by Genetically Engineered Chinese Hamster Ovary Cells - ResearchAndMarkets.com

DUBLIN--()--The "Pulmozyme" report has been added to ResearchAndMarkets.com's offering.

Developed by Genentech, Pulmozyme is a recombinant form of human deoxyribonuclease I produced by genetically engineered Chinese hamster ovary cells.

In patients with cystic fibrosis, high concentrations of extracellular DNA are commonly found in the sputum as a result of the body's innate response to respiratory infections.

This increases the viscoelasticity of the mucus, reducing pulmonary function and increasing risk of further infection. Pulmozyme hydrolyzes DNA, reducing the viscoelasticity of sputum and encouraging its clearance.

Key Topics Covered

  1. Drug Overview
  2. Product Profiles
  3. Pulmozyme: Cystic fibrosis

List of Figures

Figure 1: Pulmozyme for cystic fibrosis - SWOT analysis

Figure 2: The authors drug assessment summary of Pulmozyme for cystic fibrosis

Figure 3: Pulmozyme sales for cystic fibrosis across the US and five major EU markets, by country, 2016-25

List of Tables

Table 1: Pulmozyme drug profile

Table 2: Pulmozyme pivotal trial data in cystic fibrosis

Table 3: Pulmozyme sales for cystic fibrosis across the US and five major EU markets, by country ($m), 2016-25

For more information about this report visit https://www.researchandmarkets.com/r/k9l91f

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Respiratory Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Respiratory Drugs